156 related articles for article (PubMed ID: 16005039)
1. HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensitivity.
Louder MK; Sambor A; Chertova E; Hunte T; Barrett S; Ojong F; Sanders-Buell E; Zolla-Pazner S; McCutchan FE; Roser JD; Gabuzda D; Lifson JD; Mascola JR
Virology; 2005 Sep; 339(2):226-38. PubMed ID: 16005039
[TBL] [Abstract][Full Text] [Related]
2. Passage of HIV-1 molecular clones into different cell lines confers differential sensitivity to neutralization.
Zhang YJ; Fredriksson R; McKeating JA; Fenyö EM
Virology; 1997 Nov; 238(2):254-64. PubMed ID: 9400598
[TBL] [Abstract][Full Text] [Related]
3. Chimeric viruses expressing primary envelope glycoproteins of human immunodeficiency virus type I show increased sensitivity to neutralization by human sera.
McKeating JA; Zhang YJ; Arnold C; Frederiksson R; Fenyö EM; Balfe P
Virology; 1996 Jun; 220(2):450-60. PubMed ID: 8661395
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry.
Blish CA; Nedellec R; Mandaliya K; Mosier DE; Overbaugh J
AIDS; 2007 Mar; 21(6):693-702. PubMed ID: 17413690
[TBL] [Abstract][Full Text] [Related]
5. Escape from autologous humoral immunity of HIV-1 is not associated with a decrease in replicative capacity.
Bunnik EM; Lobbrecht MS; van Nuenen AC; Schuitemaker H
Virology; 2010 Feb; 397(1):224-30. PubMed ID: 19945135
[TBL] [Abstract][Full Text] [Related]
6. Antibody-mediated neutralization of primary human immunodeficiency virus type 1 isolates: investigation of the mechanism of inhibition.
Spenlehauer C; Kirn A; Aubertin AM; Moog C
J Virol; 2001 Mar; 75(5):2235-45. PubMed ID: 11160727
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo neutralization of HIV-1 quasi-species by a broadly reactive humanized monoclonal antibody KD-247.
Matsushita S; Takahama S; Shibata J; Kimura T; Shiozaki K; Eda Y; Koito A; Murakami T; Yoshimura K
Hum Antibodies; 2005; 14(3-4):81-8. PubMed ID: 16720978
[TBL] [Abstract][Full Text] [Related]
8. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.
Sullivan N; Sun Y; Li J; Hofmann W; Sodroski J
J Virol; 1995 Jul; 69(7):4413-22. PubMed ID: 7769703
[TBL] [Abstract][Full Text] [Related]
9. Impact of V2 mutations on escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary human immunodeficiency virus type 1 isolate.
Shibata J; Yoshimura K; Honda A; Koito A; Murakami T; Matsushita S
J Virol; 2007 Apr; 81(8):3757-68. PubMed ID: 17251298
[TBL] [Abstract][Full Text] [Related]
10. Inter-subtype cross-neutralizing antibodies recognize epitopes on cell-associated HIV-1 virions.
Donners H; Davis D; Willems B; van der Groen G
J Med Virol; 2003 Feb; 69(2):173-81. PubMed ID: 12683404
[TBL] [Abstract][Full Text] [Related]
11. Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models.
Brown BK; Wieczorek L; Sanders-Buell E; Rosa Borges A; Robb ML; Birx DL; Michael NL; McCutchan FE; Polonis VR
Virology; 2008 Jun; 375(2):529-38. PubMed ID: 18433824
[TBL] [Abstract][Full Text] [Related]
12. Epitopes corresponding to the envelope genetic subtype are present on the surface of free virions of HIV-1 group M primary isolates and can be detected in neutralization assays with extended incubation phases.
Davis D; Donners H; Willems B; Vermoesen T; Heyndrickx L; Colebunders R; van der Groen G
J Med Virol; 2003 Nov; 71(3):332-42. PubMed ID: 12966537
[TBL] [Abstract][Full Text] [Related]
13. Dual tropism of HIV-1 envelopes derived from renal tubular epithelial cells of patients with HIV-associated nephropathy.
Zerhouni-Layachi B; Husain M; Ross MJ; Marras D; Sunamoto M; Liu X; Klotman PE; Klotman ME
AIDS; 2006 Feb; 20(4):621-4. PubMed ID: 16470129
[TBL] [Abstract][Full Text] [Related]
14. Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity.
Cham F; Zhang PF; Heyndrickx L; Bouma P; Zhong P; Katinger H; Robinson J; van der Groen G; Quinnan GV
Virology; 2006 Mar; 347(1):36-51. PubMed ID: 16378633
[TBL] [Abstract][Full Text] [Related]
15. Envelope variants from women recently infected with clade A human immunodeficiency virus type 1 confer distinct phenotypes that are discerned by competition and neutralization experiments.
Painter SL; Biek R; Holley DC; Poss M
J Virol; 2003 Aug; 77(15):8448-61. PubMed ID: 12857914
[TBL] [Abstract][Full Text] [Related]
16. Postattachment neutralization of a primary strain of HIV type 1 in peripheral blood mononuclear cells is mediated by CD4-specific antibodies but not by a glycoprotein 120-specific antibody that gives potent standard neutralization.
McInerney TL; Dimmock NJ
AIDS Res Hum Retroviruses; 2001 Nov; 17(17):1645-54. PubMed ID: 11779352
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing antibodies decrease the envelope fluidity of HIV-1.
Harada S; Monde K; Tanaka Y; Kimura T; Maeda Y; Yusa K
Virology; 2008 Jan; 370(1):142-50. PubMed ID: 17900650
[TBL] [Abstract][Full Text] [Related]
18. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
[TBL] [Abstract][Full Text] [Related]
19. The neutralization sensitivity of viruses representing human immunodeficiency virus type 1 variants of diverse subtypes from early in infection is dependent on producer cell, as well as characteristics of the specific antibody and envelope variant.
Provine NM; Cortez V; Chohan V; Overbaugh J
Virology; 2012 May; 427(1):25-33. PubMed ID: 22369748
[TBL] [Abstract][Full Text] [Related]
20. Dominant-negative effect of hetero-oligomerization on the function of the human immunodeficiency virus type 1 envelope glycoprotein complex.
Herrera C; Klasse PJ; Kibler CW; Michael E; Moore JP; Beddows S
Virology; 2006 Jul; 351(1):121-32. PubMed ID: 16616288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
